Evidence map›Paper›PMID 28602044›Full record

ReviewBritish journal of pharmacology2018

The dynamic interaction between pain and opioid misuse.

Adrianne R Wilson-Poe, Jose A Morón

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Telemedicine and current clinical practice trends in the COVID-19 pandemic.Best practice & research. Clinical anaesthesiology · 2021
    Review
  13. Article
  14. Article
  15. Synthetic Studies of Neoclerodane Diterpenes fromACS chemical neuroscience · 2020
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. The dynamic interaction between pain and opioid misuse.British journal of pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adrianne R Wilson-PoePain Center, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-6304-5295
Jose A MorónPain Center, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA.
Washington University in St. Louis · US

Funding

Dissecting circuits mediating pain-induced alterations in motivated behaviorR01DA041781 · NIDA · WASHINGTON UNIVERSITY · PI MORON-CONCEPCION, JOSE A · 2017 to 2021
$2.3M
Role of SK2 channels in morphine dependenceR01DA042499 · NIDA · WASHINGTON UNIVERSITY · PI MORON-CONCEPCION, JOSE A · 2017 to 2021
$1.9M
USING TRANSGENIC MICE TO EXAMINE THE ROLE OF CNIH3 VARIANTS IN OPIOID DEPENDENCER33DA041883 · NIDA · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MORON-CONCEPCION, JOSE A · 2018 to 2020
$1.1M
Role of CB1 Receptors in Opioid Tolerance During PainR00DA041467 · NIDA · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI WILSON-POE, ADRIANNE RAE · 2019 to 2022
$831k
Role for delta opioid receptor in morphine tolerance during chronic painR21DA036826 · NIDA · WASHINGTON UNIVERSITY · PI CARLTON, SUSAN M, MORON-CONCEPCION, JOSE A · 2014 to 2015
$459k
In vivo imaging of dynamic structural plasticity driving morphine conditioned place preferenceR21DA042581 · NIDA · WASHINGTON UNIVERSITY · PI HAN, EDWARD BING, MORON-CONCEPCION, JOSE A · 2016 to 2017
$381k
USING TRANSGENIC MICE TO EXAMINE THE ROLE OF CNIH3 VARIANTS IN OPIOID DEPENDENCER21DA041883 · NIDA · WASHINGTON UNIVERSITY · PI DOUGHERTY, JOSEPH D, MORON-CONCEPCION, JOSE A · 2016 to 2017
$379k
Role of CB1 Receptors in Opioid Tolerance During PainK99DA041467 · NIDA · WASHINGTON UNIVERSITY · PI WILSON-POE, ADRIANNE RAE · 2017 to 2018
$275k
NIDA NIH HHS K99 DA041467NIDA NIH HHS R00 DA041467NIDA NIH HHS R01 DA041781NIDA NIH HHS R01 DA042499NIDA NIH HHS R21 DA036826NIDA NIH HHS R21 DA041883NIDA NIH HHS R21 DA042581NIDA NIH HHS R33 DA041883
6 · The paper itself

Abstract

In 2014, drug overdose surpassed automobile accidents as the number one cause of accidental death for the first time in the history of the United States. The overdose epidemic is largely driven by opioids, and genuine prescription opioid analgesics play the biggest role in this phenomenon. Despite advancements in abuse deterrent formulations, prescription drug monitoring programmes and clinical assessments for the detection of abuse potential, drug overdoses continue to escalate. The Center for Disease Control has recently issued new guidelines for opioid prescription, yet even these recommendations have their shortcomings. Furthermore, undertreated pain in patients with comorbid substance use disorder poses a major clinical challenge, particularly for patients on opioid replacement therapy. Despite the seemingly obvious interaction between the presence of pain and the abuse of pain-relieving opioids, there is surprisingly little mechanistic data to further our understanding of this vitally important topic. The need for novel pain interventions that minimize abuse liability is critical. Without a fundamental characterization of pain neurobiology and the interaction between chronic pain and the brain's reward system, we are unlikely to make progress in the alleviation of the opioid epidemic. LINKED ARTICLES: This article is part of a themed section on Emerging Areas of Opioid Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.14/issuetoc.

Indexed as

Analgesics, OpioidAnimalsHumansOpioid-Related DisordersPainAnalgesics, Opioid

Identifiers

PMID28602044
PMCPMC6016619
OpenAlexW2624333990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.